Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

Novo Nordisk A/S Price Quote

$90.94

Novo Nordisk A/S Key Stats

Buy
58
Novo Nordisk A/S (NVO) is a Buy

Day range:
$90.62 - $92.57
52-week range:
$49.79 - $100.88
Dividend yield:
1.14%
P/E ratio:
52.50
P/S ratio:
14.46
P/B ratio:
30.81%

Volume:
2.6M
Avg. volume:
3.9M
1-year change:
81.17%
Market cap:
$406.8B
Revenue:
$25.1B
EPS:
$2.11

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.5%

Novo Nordisk A/S Stock Price Performance

  • Did Novo Nordisk A/S Stock Go Up Last Month?
    Novo Nordisk A/S share price went down by -4.46% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 81.17% over the past 1 year

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.8B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $5.3B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 2.95

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $12.9B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$8B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 63.4%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 27.17%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 82.75%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 50.35% -4.26%
Revenue: 34.34% -2.56%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 1
Price Target: 93.60
Upside from Last Price: 2.93%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    193.2M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders